Technical Analysis for MSCL - Satellos Bioscience Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 0.400 | 5.26% | 0.020 |
MSCL closed up 5.26 percent on Wednesday, March 22, 2023, on 53 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 12 hours ago |
| Rose Above Previous Day's High | about 13 hours ago |
| Rose Above Upper Bollinger Band | about 13 hours ago |
| Up 2 ATRs | about 13 hours ago |
| Up 1 ATR | about 13 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program focuses on the development of a therapeutic for correcting the impaired muscle regenerative process in genetic pediatric disease, duchenne muscular dystrophy (DMD), a genetic disease that involves the mutation and functional disruption of the DMD gene and loss of Dystrophin. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Organ Systems Regenerative Medicine
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Organ Systems Regenerative Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.2 |
| 52 Week Low | 0.215 |
| Average Volume | 49,505 |
| 200-Day Moving Average | 0.395 |
| 50-Day Moving Average | 0.348 |
| 20-Day Moving Average | 0.368 |
| 10-Day Moving Average | 0.363 |
| Average True Range | 0.025 |
| RSI | 59.02 |
| ADX | 19.2 |
| +DI | 40.152 |
| -DI | 19.893 |
| Chandelier Exit (Long, 3 ATRs) | 0.369 |
| Chandelier Exit (Short, 3 ATRs) | 0.396 |
| Upper Bollinger Bands | 0.409 |
| Lower Bollinger Band | 0.327 |
| Percent B (%b) | 0.89 |
| BandWidth | 22.228 |
| MACD Line | 0.007 |
| MACD Signal Line | 0.006 |
| MACD Histogram | 0.0012 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.475 | ||||
| Resistance 3 (R3) | 0.482 | 0.463 | 0.463 | ||
| Resistance 2 (R2) | 0.463 | 0.444 | 0.460 | 0.458 | |
| Resistance 1 (R1) | 0.432 | 0.432 | 0.448 | 0.425 | 0.454 |
| Pivot Point | 0.413 | 0.413 | 0.421 | 0.410 | 0.413 |
| Support 1 (S1) | 0.382 | 0.394 | 0.398 | 0.375 | 0.346 |
| Support 2 (S2) | 0.363 | 0.382 | 0.360 | 0.342 | |
| Support 3 (S3) | 0.332 | 0.363 | 0.338 | ||
| Support 4 (S4) | 0.325 |
